|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/277 | (2013.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| A61K 31/337 | (2013.01) | ||
| A61K 31/405 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 31/4166 | (2013.01) | ||
| C07K 14/54 | (2006.01) | ||
| A61K 31/165 | (2006.01) | ||
| A61K 31/58 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/609 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/277 | (2006.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61K 31/337 | (2006.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61K 31/405 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/4166 | (2006.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61K 31/58 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 31/609 | (2006.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3062808 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14857072.4 |
| Date of filing the European patent application | 2014-10-27 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/062455 |
| Date | 2014-10-27 |
| (87) | Number | WO 2015/065919 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361896250 P | 2013-10-28 | US | |
| 201361914389 P | 2013-12-11 | US |
| (72) |
GAO, Allen C. , US
LIU, Chengfei , US
LOU, Wei , US
|
| (73) |
The Regents of the University of California ,
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200,
US
U.S. Government Represented by the Department of Veterans Affairs , Office of the General Counsel, Washington, DC 20420, US |
| (54) | TREATMENT OF METASTATIC PROSTATE CANCER |
| TREATMENT OF METASTATIC PROSTATE CANCER |